ANDA 76862, held by Actavis Labs Fl Inc. Metoprolol Succinate.
As of Nov 16, 2026, ANDA 76862 (Metoprolol Succinate), held by Actavis Labs Fl Inc, was first approved by FDA on Aug 3, 2009, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 3, 2009 | Original application | Approved | None posted |
| Metoprolol SuccinateEQ 50MG TARTRATE · tablet, extended release;oral | Metoprolol Succinate | Rx |
| Metoprolol SuccinateEQ 25MG TARTRATE · tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| Jun 29, 2015 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 29, 2015 | Supplement 6Labeling | Approved | None posted |
| May 15, 2014 | Supplement 13Manufacturing | Approved | None posted |
| Aug 3, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters